NSCLC cell migration and invasion has been shown to be reduced by QU treatment at different concentrations by inhibiting the transcript levels of Gap Junction Protein Beta 2 (GJB2) in these cells [72]. The gene discussed is GJB2; the disease is non-small cell lung carcinoma.